Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rushna Ali

Neurological Surgery Rochester, MN Medical Doctor

NPI 1316243512 CMS profile 196087

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$7,988

95 records reported · program years 2019–2025

Research payments

$580

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rushna Ali of Rochester, MN is reported in the CMS Open Payments database as having received $7,988 across 95 general payments and $580 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 67th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,107 6
2024 General $509 15
2024 Research $580 1
2023 General $2,848 19
2022 General $1,221 19
2021 General $663 12
2020 General $707 12
2019 General $934 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rushna Ali
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Rushna Ali were reported at $1,107. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Rushna Ali Neurological Surgery median Middle half National median
2019 $934 $582 $138–$3,006 $163
2020 $707 $294 $76–$2,174 $114
2021 $663 $387 $105–$2,432 $132
2022 $1,221 $542 $139–$2,989 $149
2023 $2,848 $534 $145–$2,697 $160
2024 $509 $574 $155–$3,046 $164
2025 $1,107 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $3,506 18 payments
  2. Abbott Laboratories $1,289 48 payments
  3. Medtronic USA, Inc. $1,135 11 payments
  4. Microtransponder, Inc. $765 5 payments
  5. Boston Scientific Corporation $687 5 payments
  6. Bioventus LLC $227 2 payments
  7. InSightec,Inc $174 1 payment
  8. Portola Pharmaceuticals, Inc. $122 1 payment
  9. Nevro Corp. $24 1 payment
  10. Baxter Healthcare $21 1 payment
  11. Other $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,267 90 payments
  2. Travel and Lodging $1,561 3 payments
  3. Consulting Fee $1,160 2 payments
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $2,327 11 payments
  2. ACTIVA $693 3 payments
  3. SenSight $580 1 payment
  4. PERCEPT PC BRAINSENSE $395 3 payments
  5. PROCLAIM $374 22 payments
  6. General - DBS $268 2 payments
  7. INFINITY $206 4 payments
  8. INTELLIS $206 1 payment
  9. Proclaim IPG $193 5 payments
  10. Neuromodulation Dspsbls and Accs $180 1 payment
  11. Other $1,412 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $580 1 payment

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$75,637

Medicare's payments for the services billed

Medicare patients

148

Average age 71

Services billed

263

66 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 58%
Depression 26%
Ischemic heart disease 24%
Chronic kidney disease 24%
Diabetes 23%
Atrial fibrillation 19%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

96 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record